Genotoxic and cytotoxic effects of doxycycline in cultured human peripheral blood lymphocytes

Drug and Chemical Toxicology

Volumn 35, Issue 3, 2012, Pages 334-340

  Şekeroǧlu, Zülal Atli ^a   Afan, Feridun ^a   Şekeroǧlu, Vedat ^a  

^a ORDU UNIVERSITY   (Turkey)

Author keywords

chromosomal aberrations; Doxycycline; micronucleus; mitotic index; nuclear division index

Indexed keywords

AVIDOXY; DOKSIN; DOXORAL; DOXYCYCLINE; DOXYCYCLINE HYCLATE; MICRODOX; MITOMYCIN C; ORAXYL; TETRADOX; UNCLASSIFIED DRUG; VIBROX;

ARTICLE; BLOOD SAMPLING; CELL CYCLE PHASE; CELL DIVISION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOKINESIS; CYTOKINESIS BLOCK MICRONUCLEUS TEST; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFECT; GENOTOXICITY; HUMAN; HUMAN CELL; IC 50; LYMPHOCYTE CULTURE; MICRONUCLEUS; MICRONUCLEUS TEST; MITOSIS; MITOSIS INDEX; NUCLEAR DIVISION INDEX; PERIPHERAL LYMPHOCYTE; RISK ASSESSMENT;

ANALYSIS OF VARIANCE; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; MITOTIC INDEX; MOLECULAR STRUCTURE; TOXICITY TESTS;

EID: 84862842535     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2011.621954     Document Type: Article

References (57)

1. Agwuh, K. N., MacGowan, A. (2006). Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58:256-265. (Pubitemid 44294934)
2. Albert, R. E., Magee, P. S. (2000). The tumorigenicity of mutagenic contact sensitizing chemicals. Risk Anal 20:317-325. (Pubitemid 30644701)
3. Anderson, D., Jenkinson, P. C., Dewdeney, R. S., Franis, A. J., Godbert, P., Butterworth, K. R. (1988). Chromosome aberrations, mitogen-induced blastogenesis, and proliferative rate index in peripheral lymphocytes from 106 control individuals of U.K. population. Mutat Res 204:407-420. (Pubitemid 18072334)
4. Anderson, B. E., Zeiger, E., Shelby, M. D., Resnick, M. A., Gulati, D. K., Ivett, J. L., et al. (1990). Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ Mol Mutagen 16:55-137.
5. Andrews, A. W., Fornwald, J. A., Lijinsky, W. (1980). Nitrosation and mutagenicity of some amine drugs. Toxicol Appl Pharmacol 52:237-244.
6. Arshad, M., Khan, Q. M., Iqbal, T., Mukhtar, K. (2005). Assessment of genotoxic effects of Doxycycline in mice by the comet assay. Rawal Med J 30:85-87.
7. Bautitz, I. R., Nogueira, R. F. P. (2007). Degradation of tetracycline by photo-fenton process-solar irradiation and matrix effects. J Photochem Photobiol Chem 187:33-39.
8. Blitek, D., Pienkowska, K., Gajcy, H., Koziorowska, J. (1983). Mutagenicity of oxytetracycline. Mutat Res 117:193-199.
9. Clark, J. M. J., Chang, A. Y. (1965). Inhibitors of the transfer of amino acids from aminoacyl soluble ribonucleic acid to proteins. J Biol Chem 240:4734-4739.
10. Çelik, A., Eke, D. (2011). The assessment of cytotoxicity and genotoxicity of tetracycline antibiotic in human blood lymphocytes using CBMN and SCE analysis, in vitro. Int J Hum Genet 11:23-29.
11. Dimitrijevic, A., Milosevic-Djordjevic, O., Grujicic, D., Arsenijevic, S. (2006). Micronucleus frequency in women with genital Chlamydia trachomatis infection before and after therapy. Mutat Res 608:43-48. (Pubitemid 44404021)
12. Eastmond, D. A., Tucker, J. D. (1989). Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody. Environ Mol Mutagen 13:34-43. (Pubitemid 19252654)
13. Evans, H. J. (1984). Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In: Kilbey, B. J., Legator, M., Nichols, W., Ramel, C. (Eds.), Handbook of mutagenicity test procedures (pp. 405-427). Amsterdam: Elsevier Science.
14. Fenech, M. (2000). The in vitro micronucleus technique. Mutat Res 455:81-95.
15. Fife, R. S., Rougraff, B. T., Proctor, C., Sledge, G. W. J. (1997). Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med 130:530-534. (Pubitemid 27526335)
16. Fife, R. S., Sledge, G. W. J., Roth, B. J., Proctor, C. (1998). Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett 127:37-41. (Pubitemid 28230783)
17. Galloway, S. (2000). Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen 35:191-201.
18. Hagiwara, M., Watanabe, E., Barrett, J. C., Tsutsui, T. (2006). Assessment of genotoxicity of 14 chemical agents used in dental practice: ability to induce chromosome aberrations in Syrian hamster embryo cells. Mutat Res 603:111-120. (Pubitemid 43224150)
19. International System for Human Cytogenetic Nomenclature (ISCN). (1985). Report of the standing committee on human cytogenetic nomenclature. Birth Defects Orig Artic 1-117.
20. Isidori, M., Lavorgna, M., Nardelli, A., Pascarella, L., Parrella, A. (2005). Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 346:87-98. (Pubitemid 40931920)
21. Jantratid, E., Strauch, S., Becker, C., Dressman, J. B., Amidon, G. L., Junginger, H. E., et al. (2010). Biowaiver monographs for immediate release solid oral dosage forms: doxycycline hyclate. J Pharmaceut Sci 99:1639-1653.
22. Kalina, I., Ondrussekova, A., Konecna, H. (1990). Relation of the occurrence of chromosome aberrations in human peripheral lymphocytes to the cell cycle. Cas Lek Cesk 129:23-25.
23. Karahalil, B., Yaǧar, S., Bahadir, G., Durak, P., Şardaş, S. (2005). Diazepam and propofol used as anesthetics during open-heart surgery do not cause chromosomal aberrations in peripheral blood lymphocytes. Mutat Res 581:181-186. (Pubitemid 40255906)
24. Kersten, B., Zhang, J., Brendler-Schwaab, S. Y., Kasper, P., Müller, L. (1999). The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. Mutat Res 445:55-71. (Pubitemid 29474934)
25. Kirsch-Volders, M, Sofuni, T, Aardemac, M, Albertini, S, Eastmond, D, Fenech, M, et al. (2003). Report from the in vitro micronucleus assay working group. Mutat Res 540:153-163. (Pubitemid 37209943)
26. Kocaman, A. Y., Topaktaş, M. (2007). In vitro evaluation of the genotoxicity of acetamiprid in human peripheral blood lymphocytes. Environ Mol Mutagen 48:483-490. (Pubitemid 47207007)
27. Kolpin, D. W., Furlong, E. T., Meyer, E. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., et al. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. Streams, 1999-2000: a national reconnaissance. Environ Sci Tech 36:1202-1211. (Pubitemid 34228893)
28. Kroon, A. M., Van den Bogert, C. (1983). Antibacterial drugs and their interference with the biogenesis of mitochondria in animal and human cells. Pharm Weekbl 5:81-87. (Pubitemid 13031470)
29. Kroon, A. M., Dontje, B. H., Holtrop, M., Van den Bogert, C. (1984). The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics. Cancer Lett 25:33-40. (Pubitemid 15221639)
30. Lawley, P. D., Brookes, P. (1963). The action of alkylating agents on deoxyribonucleic acid in relation to biological effects of the alkylating agents. Exp Cell Res 9:512-520.
31. Lopez Nigro, M. M., Palermo, A. M., Mudry, M. D., Carballo, M. A. (2003). Cytogenetic evaluation of two nitroimidazole derivatives. Toxicology in Vitro 17:35-40. (Pubitemid 36106489)
32. Mace, M. L., Jr., Daskal, Y., Wray, W. (1978). Scanning-electron microscopy of chromosome aberrations. Mutat Res 52:199-206. (Pubitemid 9019071)
33. McGregor, D. B., Brown, A. G., Howgate, S., McBride, D., Riach, C., Caspary, W. (1991). Responses of the L5178Y mouse lymphoma cell forward mutation assay V: 27 coded chemicals. Environ Mol Mutagen 17:196-219.
34. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., Zeiger, E. (1986). Salmonella mutagenicity tests II. Results from the testing of 270 chemicals. Environ Mutagen 8:1-119. (Pubitemid 16084504)
35. Myhr, B. C., McGregor, D., Bowers, L., Riach, C., Brown, A., Edwards, I., et al. (1990). L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ Mol Mutagen 16:138-167. (Pubitemid 20376837)
36. Nguyen, V. X., Nix, D. E., Gillikin, S., Schentag, J. J. (1989). Effect of oral antacid administration of the pharmacokinetics of intravenous doxycycline. Antimicrob Agents Chemother 33:434-436. (Pubitemid 19094268)
37. Physicians' Desk Reference (PDR). (2005). Physicians' Desk Reference, 59th ed. Montvale, New Jersey, USA: Thomson PDR.
38. Poddar, S., Talukder, G., Sharma, A. (2004). Chromosome damage induced by ferric chloride in human peripheral lymphocytes. Int J Hum Genet 4:261-264.
39. Preston, R. J., San Sebastian, J. R., McFee, A. F. (1987). The in vitro human lymphocyte assay for assessing the clastogenicity of chemical agents. Mutat Res 189:175-183. (Pubitemid 17144431)
40. Rawal, S. Y., Rawal, Y. B. (2001). Non-antimicrobial properties of tetracyclines dental and medical implications. W Indian Med J 50:105-108. (Pubitemid 32758143)
41. Rojas, E., Herrera, L. A., Sordo, M., Gonsebatt, M. E., Montero, R., Rodriguez, R., et al. (1993). Mitotic index and cell proliferation kinetics for the identification of antineoplastic activity. Anti Canc Drugs 4:637-640. (Pubitemid 24026216)
42. Rothfuss, A, Schutz, P, Bochum, S, Volm, T, Eberhardt, E, Kreienberg, R, et al. (2000). Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390-394. (Pubitemid 30070767)
43. Rubins, J. B., Charboneau, D., Alter, M. D., Bitterman, P. B., Kratzke, R. A. (2001). Inhibition of mesothelioma cell growth in vitro by doxycycline. Lab Clin Med 138:101-106. (Pubitemid 32696273)
44. Saikali, Z., Singh, G. (2003). Doxycycline and other tetracyclines in the treatment of bone metastasis. Anti Canc Drugs 14:773-778. (Pubitemid 38339780)
45. Seligmann, I. C., Lima, P. D., Cardoso, P. C., Khayat, A. S., Bahia, M. O., Buchi, D. F., et al. (2003). The anticancer homeopathic composite "Canova Method" is not genotoxic for human lymphocytes in vitro. Genet Mol Res 2:223-228. (Pubitemid 38888796)
46. Smilack, J. D. (1999). The tetracyclines. Mayo Clin Proc 74:727-729.
47. Snyder, R. D., Green, J. W. (2001). A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 488:151-169. (Pubitemid 32436429)
48. Suzuki, H. (1987). Assessment of the carcinogenic hazard of 6 substances used in dental practice. Part II. Morphologicaltransformation, DNA damage, and sister chromatid exchanges in cultured Syrian hamster embryo cells induced by formocresol, iodoform, zinc oxide, chloroform, chloramphenicol, and tetracycline hydrochloride. Odontology 74:1385-1403.
49. Titenko-Holland, N., Windham, G., Kolachana, P., Reinisch, F., Parvatham, S., Osorio, A. M., et al. (1997). Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion-exposed workers. Mutat Res 388:85-95. (Pubitemid 27226926)
50. Tsutsui, T., Umeda, M., Sou, M., Maizumi, H. (1976). Effect of tetracycline on cultured mouse cells. Mutat Res 40:261-268.
51. U.S. Food and Drug Administration (FDA). (1997). Center for Drug Evaluation and Research, pharmacology reviews. Application number: NDA 50-744. Silver Spring, Maryland, USA: CDER.
52. U.S. Food and Drug Administration (FDA). (2004). Center for Drug Evaluation and Research, pharmacology reviews. Application number: NDA 50-795. Silver Spring, Maryland, USA: CDER.
53. Van den Bogert, C., Dontje, B. H., Kroon, A. M. (1985). The antitumour effect of doxycycline on a T-cell leukaemia in the rat. Leuk Res 9:617-623. (Pubitemid 15059262)
54. Van den Bogert, C., Dontje, B. H. J., Holtrop, M., Melis, T. E., Romijn, J. C., Van Dongen, J. W., et al. (1986a). Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 46:3283-3289. (Pubitemid 16096857)
55. Van den Bogert, C., Van Kernebeek, G., De Leij, L., Kroon, A. M. (1986b). Inhibition of mitochondrial protein synthesis leads to proliferation arrest in the G1-phase of the cell cycle. Cancer Lett 32:41-51. (Pubitemid 16047960)
56. Xue, W., Warshawsky, D. (2005). Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73-93. (Pubitemid 40800430)
57. Zeiger, E., Haworth, S. (1985). Tests with a preincubation modification of the Salmonella microsome assay. In: Ashby, J., deSerres, F., Draper, M., Ishidate, M.J., Margolin, B., Matter, B., et al. (Eds.), Evaluation of short-term test for carcinogens (pp. 187-199). New York: Elsevier.